Anti-CD19 antibody drug conjugates
US12121589B2 · kind B2 · utility
0Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2023 |
| Grant date | Oct 22, 2024 |
| Priority date | — |
| Expiry date | Jun 15, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides anti-CD19 antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.